Year: 2025
Type: article
Abstract: Heart failure (HF) remains a leading cause of morbidity and mortality worldwide, with acute HF (AHF) or cardiogenic shock requiring rapid intervention to prevent fatal outcomes. Advances in temporary mechanical circulatory support (tMCS) devices have revolutionized the management of advanced HF, offering temporary, durable, and individualized support options. This manuscript reviews the pathophysiology and clinical presentation of AHF, the role of multi-disciplinary Heart Teams, and the growing importance of structured care networks in managing complex cases of HF. We explore the strategic deployment of tMCS in acute settings, device options, implications for patient outcomes, and current challenges in the field. This manuscript emphasizes the importance of team-based approaches and underscores the potential of tMCS devices in stabilizing patient haemodynamics, bridging to recovery or definitive therapy, and improving survival in patients facing high-risk HF.
Institutions: Royal Brompton & Harefield NHS Foundation Trust, Harefield Hospital, Royal Brompton Hospital, Onze Lieve Vrouwziekenhuis Hospital, Imperial College London, IRCCS Humanitas Research Hospital, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Krankenhaus der Barmherzigen Brüder Trier, Amsterdam UMC Location Vrije Universiteit Amsterdam, Deutsches Herzzentrum der Charité, Medical University of Vienna, Università degli Studi di Enna Kore
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: hybrid
Funder: Abiomed
OpenAlex ID: W4407120513